Aberrant HDAC3 expression correlates with brain metastasis in breast cancer patients

BACKGROUND: Brain metastasis is an unsolved clinical problem in breast cancer patients due to its poor prognosis and high fatality rate. Although accumulating evidence has shown that some pan‐histone deacetylase (HDAC) inhibitors can relieve breast cancer brain metastasis, the specific HDAC protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Li, Qi, Lisha, Li, Shuangjing, Yin, Qiang, Liu, Jinmei, Wang, Jingyi, She, Chunhua, Li, Peng, Liu, Qun, Wang, Xiaoguang, Li, Wenliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471029/
https://www.ncbi.nlm.nih.gov/pubmed/32686908
http://dx.doi.org/10.1111/1759-7714.13561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471029/
https://www.ncbi.nlm.nih.gov/pubmed/32686908
http://dx.doi.org/10.1111/1759-7714.13561

Ejemplares similares